Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
496 hedge funds and large institutions have $15.1B invested in Abiomed Inc in 2021 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 161 increasing their positions, 181 reducing their positions, and 57 closing their positions.
14% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 57
12% more capital invested
Capital invested by funds: $13.4B → $15.1B (+$1.64B)
8% more call options, than puts
Call options by funds: $103M | Put options by funds: $95M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% less funds holding
Funds holding: 498 → 496 (-2)
11% less repeat investments, than reductions
Existing positions increased: 161 | Existing positions reduced: 181
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$152M |
| 2 |
BlackRock
New York
|
+$97.1M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$42.3M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$42.3M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$38.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$78.2M |
| 2 |
MAMU
Marathon Asset Management (UK)
London,
United Kingdom
|
-$65.7M |
| 3 |
Primecap Management
Pasadena,
California
|
-$44.9M |
| 4 |
Renaissance Technologies
New York
|
-$38M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$36.7M |
ABMD Hedge Fund Activity: Q4 2021 in Review
496 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2021, worth a combined $15.1B — up 12% from $13.4B a quarter earlier.
Buyers outnumbered sellers: 65 funds opened new ABMD positions and 57 closed out — a net gain of 8 holders — while 161 added to existing stakes and 181 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $152M. The largest seller was Wells Fargo, cutting an estimated $78.2M.
- 496 institutional investors held Abiomed Inc (ABMD) as of Q4 2021, down from 498 in Q3 2021.
- Funds reported $15.1B of Abiomed Inc stock for Q4 2021, up 12% quarter-over-quarter.
- 65 funds opened new Abiomed Inc positions in Q4 2021 and 57 closed out, a net change of +8 holders.
- The largest Abiomed Inc buyer in Q4 2021 was Wellington Management Group, an estimated $152M added.
- The largest Abiomed Inc seller in Q4 2021 was Wells Fargo, an estimated $78.2M sold.
Based on aggregated 13F filings for Q4 2021.